Navigation Links
John A. Orwin Joins Array BioPharma Board Of Directors
Date:11/7/2012

BOULDER, Colo., Nov. 7, 2012 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced that as part of its continued evolution toward late-stage development and commercialization, John A. Orwin, chief executive officer of Affymax, Inc., joined the Company's board of directors, effective November 6, 2012.

(Photo: http://photos.prnewswire.com/prnh/20121107/LA07637)

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

Mr. Orwin has served as the chief executive officer of Affymax since 2011, after joining the company in 2010 as its chief operating officer.  Previously, he held leadership roles in marketing, sales, and operations for major pharmaceutical companies including Genentech, Johnson & Johnson, Alza Pharmaceuticals, Rhone-Poulenc Rorer, and Schering-Plough Corporation.

Mr. Orwin brings a track record of substantial accomplishment in the pharmaceutical industry to Array's board of directors. Over his career, Mr. Orwin has built successful businesses and commercialized a range of blockbuster products.  Most recently, he led the approval and launch of Omontys®, a hematology product for the treatment of anemia in chronic kidney disease.  Prior to joining Affymax, he led Genentech's BioOncology business unit and grew a portfolio of cancer-fighting products including Avastin®, Rituxan®, Herceptin® and Tarceva® to over $7 billion in U.S. sales.  Earlier in his career, he was responsible for the successful launch of Taxotere®, exceeding budget and forecast expectations.

Ron Squarer, chief executive officer of Array, noted, "At a time when Array is moving towards commercialization of our pipeline, John has the perfect background to compleme
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
2. Robert Farrell Joins Bionovos Board of Directors
3. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
4. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
5. First Choice Rehabilitation Specialists Joins Select Medical
6. Excel Life Sciences Joins DATATRAKs Connect Partner Program
7. Marina Biotech, Inc. Joins OTCQX
8. Richard H. Scheuermann, Ph.D. Joins J. Craig Venter Institute as Director of Informatics
9. Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market
10. QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to Worlds Poorest Countries
11. Cancer Immunotherapy Expert Joins Pacific Meso Center Research Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014 Texas Governor Rick ... Texas A&M Health Science Center CEO Brett Giroir, ... Health and Human Services (HHS), State of Texas ... pandemic influenza vaccine manufacturing facility in Bryan, Texas, ... for the Texas A&M Biocorridor – a rapidly ...
(Date:9/18/2014)... 18, 2014 Research and Markets ... Chinese Stem Cell Industry Report, 2014-2017" report to ... biological cells that can differentiate into specialized cells and ... Stem cell therapy can be applied to treatment of ... nervous system diseases, damage or lesion of liver, kidney ...
(Date:9/18/2014)... -- Research and Markets has announced the ... 2014" report to their offering. ... professional and in-depth study on the current state of ... provides a basic overview of the industry including definitions, ... market analysis is provided for the international markets including ...
(Date:9/18/2014)... 18, 2014 Leatherwood Plastics has ... material, to stay competitive in the semiconductor, clean ... materials ultimately impact product quality and productivity, according ... , Established in 1980 in Lewisville, TX, ... fabricators have left the business. Much of Leatherwood’s ...
Breaking Biology Technology:Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2
... MARLBOROUGH, Mass., July 21, 2011 Advanced Cell Technology, ... of regenerative medicine, announced today that it has entered ... Ltd. ("CHA Biotech"), a leading South Korea-based biotechnology company, ... international joint venture, Stem Cell & Regenerative Medicine International ...
... University Medical Center have discovered a way to block ... responsible for the largest number of sexually transmitted infections ... included Duke University microbiologists and chemists, designed a molecule ... The therapies that could come from this discovery mark ...
... Regulus Therapeutics Inc ., a biopharmaceutical company leading the ... announced that it has identified a third microRNA target ... milestone payment from GSK. This selection represents another significant ... which is focused on the discovery and development of ...
Cached Biology Technology:ACT Obtains Exclusive License for Hemangioblast Technology in North America 2ACT Obtains Exclusive License for Hemangioblast Technology in North America 3ACT Obtains Exclusive License for Hemangioblast Technology in North America 4ACT Obtains Exclusive License for Hemangioblast Technology in North America 5Newly designed molecule blocks chlamydia bacteria 2Newly designed molecule blocks chlamydia bacteria 3Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 2Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 3Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 4
(Date:9/18/2014)... 2014Many Americans across racial and ethnic groups describe ... on their day-to-day life, more so than other ... speech (57% of African-Americans, 49% of non-Hispanic whites, ... asked which disease or ailment is the worst ... among African-Americans followed by AIDS/HIV. Hispanics and ...
(Date:9/18/2014)... carbon and nitrogen comprise all spheres of our ... have caused imbalances and perturbations that resulted in ... GHGs result in climate changes which influence the ... the atmosphere. Understanding these feedback mechanisms has become ... science during the past three decades. , In ...
(Date:9/18/2014)... probably the ultimate form of camouflage: you don,t just ... strategy is not as uncommon as you might think. ... USA, explains that the larval life stages of many ... of the anatomy that most creatures cannot make transparent. ... to shield each individual eye unit with an opaque ...
Breaking Biology News(10 mins):Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Greenhouse gas research enters a new era 2Transparent larvae hide opaque eyes behind reflections 2
... may choose their mate with the help of smell. They ... more efficient immune system. This has been shown in a ... a Swedish-French collaboration. Humans and many animals can choose ... right smell can give the offspring an efficient immune system. ...
... Efforts to begin human clinical trials using stem ... a $37.3 million boost from the California Institute for ... on Sept. 5. UC Irvine scientists will ... Team Therapy Development Awards, which are designed to accelerate ...
... genus Hematodinium are a big problem for crab, ... in BioMed Central,s open access journal Aquatic Biosystems ... crangon ), these parasites have bacteria-like endosymbionts. The presence of ... of Hematodinium . Hematodinium sp. and ...
Cached Biology News:State stem cell research funding agency awards $37.3 million to aid UC Irvine efforts 2State stem cell research funding agency awards $37.3 million to aid UC Irvine efforts 3Lifestyle of a killer 2
... jetSI-ENDO-FluoF is a fluorescein-conjugated ... emission at 520 nm), the ... reagents are used to determine ... the intracellular delivery and trafficking ...
... and Tissue Staining Kits are intended for ... of histological and cytological specimens. These kits ... manufactured by either R&D Systems or by ... the formation of the Avidin-Biotin Complex (ABC) ...
... Purification Protocols covers a wide range of ... and experienced researchers in all areas of ... from the books preface illustrates just how ... research library., The chapters introduce the theoretical ...
... TSQ Quantum Ultra defines a new standard ... analysis. It features the revolutionary Ion ... titanium skimmer with superior skimming and larger ... Its redesigned ion transfer tube lens with ...
Biology Products: